Assignee
CHENGDU RUIMU BIOPHARMACEUTICALS CO LTD
CN·0 granted patents·5 pending applications·0 citations·filing 2021–2022
Top patents by PatentIndex Score
5 records- 0171US2024299291A1Ophthalmic preparation administered by eye drops and used for preventing and treating dry macular degeneration and retinal light damageCHENGDU RUIMU BIOPHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 0271US2025281395A1Ophthalmic preparation for treating macular edema, optic neuritis and non-infectious endophthalmitis through eye drop administrationCHENGDU RUIMU BIOPHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 0369US2025017848A1Carrier or auxiliary material of ophthalmic preparation, preparation method therefor, and application thereofCHENGDU RUIMU BIOPHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 0463US2025000791A1Ophthalmic formulation for preventing and/or treating cataracts by eye drop administrationCHENGDU RUIMU BIOPHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0561US2025064725A1Ophthalmic preparation of tyrosine kinase inhibitor, and preparation method therefor and use thereofCHENGDU RUIMU BIOPHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CHENGDU RUIMU BIOPHARMACEUTICALS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →